AVING News reported on June 11, 2026 that NeuroTx will present its personalized electroceutical platform at BIO International Convention 2026 in San Diego. The company plans to showcase solutions designed for the prevention and management of chronic neurological conditions including sleep disorders, cognitive impairment, and Parkinson's disease.
In an expert column for AVING News, Kim Dong-ju, CEO of NeuroTx and professor at Korea University, warned that South Korea's chronic sleep deprivation could become a major public health concern linked to dementia risk. He explained that deep sleep is associated with the brain's waste-clearing processes, while persistent sleep disorders may increase the risk of cognitive decline and neurodegenerative disease.
Kim Dong-ju, CEO of NeuroTx, received the K-Bio Health Award in the AI-based digital therapeutics category at MoneyToday's 2026 12th Korea Industry Awards ceremony, held at the Korea Press Center in Seoul.
NeuroTx announced that WillSleep, its sleep wellness device, received a CES 2026 Innovation Award in the Digital Health category. The company said its personalized approach, combining AI-based biosignal analysis with neurostimulation technology, was recognized for technical maturity on the global stage.
Seven startups backed by Kakao Ventures are set to participate in CES 2026, the global consumer electronics exhibition held in Las Vegas from January 6 to 9. NeuroTx, a developer of sleep support solutions, was recognized with a CES Innovation Award in the Digital Health category.
The article frames CES participation as a shift from technical demonstrations to business models that can affect real human problems. The highlighted startups focus on concrete pain points such as sleep, logistics, and daily health.
In a first-hand column, the writer describes visiting NeuroTx, a sleep-tech startup founded by a university professor. After a survey and brainwave test, the founder explained the results and discussed possible causes of insomnia.
NeuroTx received a CES 2026 Innovation Award for WillSleep, a sleep support device using non-invasive vagus nerve stimulation technology.
Health Chosun reported on Korean companies recognized in the CES 2026 Innovation Awards, with Digital Health among the leading categories.
Forbes Korea interviewed NeuroTx CEO Dong-Joo Kim about patient-centered personalized treatment through AI-based electroceutical technology.
The article introduces NeuroTx as a startup developing electroceutical approaches for sleep disorders. Electroceuticals are electronic devices that use electrical stimulation inspired by biological signals generated in the brain and nerve cells.
NeuroTx showcased WillSleep, a wellness device designed for sleep management, and WillCog, a digital therapeutic concept for supporting cognitive function.
NeuroTx is building a staged growth model from wellness products to hospital-based neuro-intervention solutions and BCI platform licensing.
Wellness Market
Step 1
Medical B2B
Step 2
BCI Platform Licensing
Step 3
Partnership Growth
Ongoing
Subscribe to receive product updates, research news, and partnership announcements.
We respect your privacy. Unsubscribe anytime.
Update areas
NeuroTx highlights
Follow NeuroTx as we advance Neural Decoding AI, personalized neuro-intervention, and next-generation BCI platforms.
